Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=33534775&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215
Case Report: Iliopsoas Hematoma during the Clinical Course of Severe COVID-19 in Two Male Patients #MMPMID33534775
Nakamura H; Ouchi G; Miyagi K; Higure Y; Otsuki M; Nishiyama N; Kinjo T; Nakamatsu M; Tateyama M; Kukita I; Fujita J
Am J Trop Med Hyg 2021[Jan]; 104 (3): 1018-1021 PMID33534775show ga
Anticoagulation plays a major role in reducing the risk of systematic thrombosis in patients with severe COVID-19. Serious hemorrhagic complications, such as intracranial hemorrhage, have also been recognized. However, intra-abdominal hemorrhage is under-recognized because of its rare occurrence, despite high mortality. Here, we discuss two cases of spontaneous iliopsoas hematoma (IPH) likely caused by anticoagulants during the clinical course of COVID-19. We also explored published case reports to identify clinical characteristics of IPH in COVID-19 patients. The use of anticoagulants may increase the risk of lethal IPH among COVID-19 patients becsuse of scarce data on optimal dosage and adequate monitoring of anticoagulant effects. Rapid diagnosis and timely intervention are crucial to ensure good patient outcomes.
free
free
free
Am+J+Trop+Med+Hyg 2021 ; 104 (3): 1018-1021
